Lee Eun Nam, Kim Moon Ja
Department of Nursing, Dong-A University, Busan, Republic of Korea.
Department of Nursing, Dong-A University, Busan, Republic of Korea.
Asian Nurs Res (Korean Soc Nurs Sci). 2019 Feb;13(1):1-10. doi: 10.1016/j.anr.2018.11.005. Epub 2018 Nov 24.
Pulmonary rehabilitation (PR) programs are important in the treatment of patients with chronic obstructive pulmonary disease (COPD) but vary widely in type, duration, and efficacy. This meta-analysis investigated the effect of PR programs on respiratory muscle strength in patients with COPD.
PubMed, Embase, and CINAHL were searched. The primary outcome variables were maximal expiratory pressure (MEP) and maximal inspiratory pressure (MIP). The secondary outcome variables were the modified Borg score after the 6-min walking test, percent predicted forced expiratory volume in 1 second (FEV%pred), and percent FEV/forced volume capacity (FVC). Comprehensive Meta-Analysis, version 3.0, was used to analyze the data. The effect size was calculated using the standardized mean difference (SMD) and 95% confidence interval (CI).
Twenty randomized controlled trials (with 992 participants) were included in the analysis. The PR programs had a significant effect on the MEP (SMD, 0.87; 95% CI, 0.42-1.32; p < .001), MIP (SMD, 0.53; 95% CI, 0.13-0.93; p = .009), and modified Borg score (SMD, -0.37; 95% CI, -0.52 to -0.22; p < .001) in patients with COPD. There was no effect on FEV%pred (SMD, 0.09; 95% CI, -0.12 to 0.30; p = .406) or FEV/FVC% (SMD, 0.04; 95% CI, -0.17 to 0.26; p = .702).
PR programs improve respiratory muscle strength in patients with COPD. Strategies for selecting a suitable PR program need to be developed, and future studies should evaluate the long-term effects of such programs on pulmonary function.
肺康复(PR)计划在慢性阻塞性肺疾病(COPD)患者的治疗中很重要,但在类型、持续时间和疗效方面差异很大。这项荟萃分析研究了PR计划对COPD患者呼吸肌力量的影响。
检索了PubMed、Embase和CINAHL。主要结局变量为最大呼气压力(MEP)和最大吸气压力(MIP)。次要结局变量为6分钟步行试验后的改良Borg评分、第1秒用力呼气容积预测值百分比(FEV%pred)和FEV/用力肺活量百分比(FVC)。使用综合荟萃分析3.0版对数据进行分析。效应大小使用标准化均数差(SMD)和95%置信区间(CI)计算。
分析纳入了20项随机对照试验(992名参与者)。PR计划对COPD患者的MEP(SMD,0.87;95%CI,0.42 - 1.32;p <.001)、MIP(SMD,0.53;95%CI,0.13 - 0.93;p =.009)和改良Borg评分(SMD, - 0.37;95%CI, - 0.52至 - 0.22;p <.001)有显著影响。对FEV%pred(SMD,0.09;95%CI, - 0.12至0.30;p =.406)或FEV/FVC%(SMD,0.04;95%CI, - 0.17至0.26;p =.702)无影响。
PR计划可改善COPD患者的呼吸肌力量。需要制定选择合适PR计划的策略,未来的研究应评估此类计划对肺功能的长期影响。